HLA-DQ2 peptide vaccine companion diagnostic - ImmusanTAlternative Names: Nexvax2 Diagnostic - ImmusanT
Latest Information Update: 16 Jul 2016
At a glance
- Originator ImmusanT
- Class Diagnostic agents
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Coeliac disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Coeliac disease(Diagnosis) in Australia
- 15 Mar 2011 Preclinical trials in Coeliac disease in Australia (unspecified route)